Insulet (PODD) Tops Q2 EPS by 25c

Insulet (NASDAQ: PODD) reported Q2 EPS of $1.17, $0.25 better than the analyst estimate of $0.92. Revenue for the quarter came in at $649.1 million versus the consensus estimate of $614.18 million.

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (
• UBS Upgrades IJM Corp Bhd (IJM:MK) to Buy
• Sohu.com, Inc. (SOHU) Reports Q2 EPS of $0.02; offers outlook